Practice Short cuts

Imatinib is effective long term treatment for myeloid leukaemia

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7581.1266-c (Published 14 December 2006) Cite this as: BMJ 2006;333:1266

The tyrosine kinase inhibitor imatinib has been a first line treatment for chronic myeloid leukaemia for several years, since early trials showed it was better than existing treatments at preventing progression of the disease and prolonging survival. Observational data from a five …

View Full Text

Sign in

Log in through your institution

Subscribe